WEE1 and neoplasm: Nevertheless, in patients with HNC, the Wee1 inhibitor adavosertib has shown favorable safety, tumor response, and survival as an adjuvant to platinum chemoradiotherapy [55] as well as high tolerability and overall responses when combined with cisplatin and docetaxel [56].